1
Open
[.]
2
Close
[.]
3
Allotment
—
4
Listing
[.]
Listing Date
[.]
✦ AI Insight
Restated Financials (₹ Cr.)
| Period Ended | 30 Sep 2024 | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 |
|---|---|---|---|---|
| Assets | 1,891.86 | 2,040.21 | 734.77 | 677.54 |
| Total Income | 315.87 | 407.99 | 420.21 | 293.11 |
| Profit After Tax | -24.93 | -0.36 | 42.42 | 50.46 |
| NET Worth | 1,192.51 | 1,190.96 | 564.90 | 503.21 |
| Reserves and Surplus | 1,048.91 | 1,047.37 | 446.58 | 419.58 |
| Total Borrowing | 405.49 | 261.69 | 48.57 | 47.20 |
| Amount in ₹ Crore |
Objects of the Issue
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Capital expenditure towards procurement of equipment and machinery | 50.00 |
| 2 | Investment in our Material Subsidiary, Bioneeds India Private Limited for capital expenditure towards procurement of equipment and machinery | 35.00 |
| 3 | Investment in our Material Subsidiary, Bioneeds India Pvt.Ltd. for Repayment/pre-payment, in part or full of certain borrowings of Bioneeds India Pvt.Ltd. | 10.89 |
| 4 | Funding organic growth of Company, our Material Subsidiary, Bioneeds India Pvt.Ltd. and Health Data Specialists (Holdings) Ltd. through marketing and promotional activities, updation of technology and adoption of modern digital solutions in workflows to enhance the efficiency and quality assurance of our operating processes and data management | 33.00 |
| 5 | General corporate purposes | |
| Total | 128.89 |
About Veeda Clinical Research IPO
Founded in April 2004, Veeda Clinical Research Limited is a full-service contract research organization (CRO) providing a comprehensive range of services in drug development, including non-clinical, pre-clinical, bioavailability, bioequivalence studies, and clinical trials for various drugs such as novel entities, generics, and biosimilars, as well as medical devices. The company's services include the following. Early-phase and late phase clinical trials Healthy volunteer studies (“HVS”) which include bioavailability studies and bioequivalence studies Pre-clinical trials and non-clinical testing biopharma services include non-clinical analysis and clinical bioanalysis of large molecules. As of September 30, 2024, the company completed 119 global regulatory inspections in HVS and Pre-Clinical services by authorities including the FDA, UK-MHRA, WHO, ANVISA, DCGI, EMA, and NPRA. As of September 30, 2024, the company has over 436 active clients worldwide. The company has successfully conducted studies for 417, 504, 498, and 580 clients during the six months ending September 30, 2024, and for the financial years 2024, 2023, and 2022, respectively. As of September 2024, the company empl
Contact Details
Veeda Clinical Research Ltd. AddressShivalik Plaza –A, 2nd FloorOpposite Ahmedabad Management AssociationAmbawadiAhmedabad, Gujarat, 380015+91 79 6777 3000investor.relation@veedalifesciences.comVisit Website